WASHINGTON, D.C. — The Food and Drug Administration (FDA) announced that Abbott has initiated a voluntary recall for a ...

Abbott, a leader in diabetes tech with one of the biggest lines of continuous glucose monitors, announced this week that it's ...

Some people are facing delays in filling prescriptions for the glucose sensor. Abbott expects to resolve the problem soon.

Abbott launched an over-the-counter continuous glucose monitoring system, Lingo, for adults not on insulin -- the second such ...

Thursday, Abbott Laboratories ABT said it is recalling some FreeStyle Libre 3 sensors after finding that a small number of FreeStyle Libre 3 sensors may provide incorrect high glucose readings.

Abbott Diabetes Care, Inc. is recalling its FreeStyle Libre 3 sensors after finding a small number of the sensors may provide incorrect high glucose readings, which, if undetected may pose ...

DexCom's revised FY24 sales guidance in the Q2 earnings call led to a $18bn valuation reset. Read why I think DXCM stock is a ...

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...

"Beta Bionics developed the iLet Bionic Pancreas to offer the type 1 community a way to manage their diabetes with less burden and more convenience. Part of that convenience is offering choice ...

Abbott's wearable FreeStyle Libre 3 device – which is billed as the smallest and thinnest real-time CGM system available – sends glucose readings every minute directly to the user's smartphone ...

Name Insider Ownership Earnings Growth Atour Lifestyle Holdings (NasdaqGS:ATAT) 26% 23.2% GigaCloud Technology (NasdaqGM:GCT) 25.7% 24.3% ...

The iLet and FreeStyle Libre 3 Plus will also be available through durable medical ... Disclaimer: You are now leaving PharmiWeb.com website and are going to a website that is not operated by us. We ...